Literature DB >> 19016034

The role of radiation therapy after incomplete resection of penile cancer.

Tanja Langsenlehner1, Ramona Mayer, Franz Quehenberger, Ulrike Prettenhofer, Uwe Langsenlehner, Karl Pummer, Karin S Kapp.   

Abstract

PURPOSE: To retrospectively assess the outcome in patients treated with adjuvant radiotherapy for penile cancer. PATIENTS AND METHODS: Between 1987 and 2006, 24 patients (median age, 62.7 years; range, 35.5-90.4 years) with squamous cell carcinoma of the penis (T1, n = 10; T2, n = 11; T3, n = 3) received megavoltage external radiotherapy (n = 22) or (192)Ir high-dose-rate brachytherapy (n = 2) following total penectomy (n = 7), partial penectomy (n = 10), or local excision (n = 7); lymphadenectomy was performed in eight patients. In 14 patients, radiotherapy was delivered after incomplete tumor resection, and in 20 patients the planning target volume included the regional lymph nodes. Median total dose of external radiotherapy was 56 Gy/1.8-2 Gy (range, 50-60 Gy). Brachytherapy was given with a total dose of 45 Gy/3 Gy.
RESULTS: During a median follow-up of 58.4 months, penile or perineal recurrence was found in four patients giving a 5-year local control rate of 74.8%. Regional failure occurred in two patients. 5-year metastases-free survival and progression-free survival rates were 86.7% and 64.5%, respectively. Four patients died due to tumor progression. The actuarial 5-year cause-specific and overall survival rates were 84.3 and 56.6%, respectively.
CONCLUSION: Radiation therapy is a successful method of treatment for penile cancer in terms of local control and organ preservation after microscopically incomplete surgery. Radiotherapy of the regional lymph nodes might also be effective in preventing regional recurrence and can be considered in case of high-risk features and following excision of extensive lymph node involvement.

Entities:  

Mesh:

Year:  2008        PMID: 19016034     DOI: 10.1007/s00066-008-1818-2

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  5 in total

1.  Organ-sparing treatment of penile cancer with interstitial pulsed-dose-rate brachytherapy.

Authors:  Johannes Seibold; Vratislav Strnad; Rainer Fietkau
Journal:  Strahlenther Onkol       Date:  2016-06-09       Impact factor: 3.621

2.  Radiotherapy plus chemotherapy versus chemotherapy alone in penile cancer patients with extracapsular nodal extension after inguinal lymph node surgery: a multi-institutional study.

Authors:  Zai-Shang Li; Xue-Ying Li; Bin Wang; Peng Chen; Xiang Li; Ornellas Antonio Augusto; Zi-Ke Qin; Zhuo-Wei Liu; Yong-Hong Li; Hui Han; Fang-Jian Zhou
Journal:  World J Urol       Date:  2020-04-17       Impact factor: 4.226

3.  Penile cancer brachytherapy HDR mould technique used at the Holycross Cancer Center.

Authors:  Robert Matys; Iwona Kubicka-Mendak; Jarosław Lyczek; Piotr Pawłowski; Iwona Stawiarska; Joanna Miedzinska; Paweł Banatkiewicz; Aldona Laskawska-Wiatr; Justyna Wittych
Journal:  J Contemp Brachytherapy       Date:  2011-12-30

4.  How to deal with penile carcinoma inguinal metastases invading femoral vessels.

Authors:  Marius Fodor; Bogdan Petrut; Lucian Fodor
Journal:  Clujul Med       Date:  2017-10-20

Review 5.  Penile cancer: a Brazilian consensus statement for low- and middle-income countries.

Authors:  Andrey Soares; Icaro Thiago de Carvalho; Aluízio Gonçalves da Fonseca; Antonio Machado Alencar; Carlos Heli Bezerra Leite; Diogo Assed Bastos; João Paulo Holanda Soares; Katia Ramos Moreira Leite; Mário Ronalsa Brandão Filho; Ronald Wagner Pereira Coelho; Sandro Roberto de A Cavallero; Stênio de Cassio Zequi; José de Ribamar Rodrigues Calixto
Journal:  J Cancer Res Clin Oncol       Date:  2020-10-26       Impact factor: 4.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.